Featured Research

from universities, journals, and other organizations

New drug against malaria effective: Uses synchrotron light

Date:
July 21, 2014
Source:
Universitat Politècnica de Catalunya (UPC)
Summary:
The CD27 drug is a true alternative against malaria, researchers now report. They have analyzed the crystalline structure of the DNA with the drug by performing X-ray diffraction experiments at the ALBA synchrotron.

Researchers from the Universitat Politècnica de Catalunya · BarcelonaTech (UPC), the Instituto de Química Mèdica (IQM-CSIC) and the University of Glasgow have proved that the CD27 drug is a true alternative against malaria. They have analysed the crystalline structure of the DNA with the drug by performing X-ray diffraction experiments at the ALBA synchrotron.

An international group of researchers led by Lourdes Campos from the Department of Chemical Engineering at the Universitat Politècnica de Catalunya · BarcelonaTech (UPC) has proved that the CD27 drug can be a reliable option against malaria. Researchers came to this conclusion after studying the 3D crystalline structure of the complex of DNA with the drug.

The CD27 drug is a complex synthesised by researchers led by Christophe Dardonville at the Instituto de Química Médica of the Spanish National Research Council's/ (IQM-CSIC) in Madrid. "CD27 is chemically related to diamidines -- molecules with two amidines -- and has previously been used with success in other Trypanosoma species that produce the 'sleeping sickness' in Africa and Chagas disease in South America," says Lourdes Campos.

Results show how the CD27 drug completely covers the minor groove of the DNA, preventing the typical development of the parasite and causing its death.

This research helps to understand this family of compounds and may significantly contribute to the development of new, more effective drugs against malaria.

Obtaining the DNA crystal

Once the samples of the drug were validated by Harry P. De Koning, a researcher at the University of Glasgow, they were sent to the UPC research group in Crystallography, Structure and Function of Biological Macromolecules (MACROM) led by Lourdes Campos. For over a year, the group has been working to obtain the crystalline structure of DNA.

Obtaining a DNA crystal is a multiparametric process -- it requires different variables -- and, before obtaining a DNA crystal with the drug, several tests under different conditions are required. The crystal must present a very high molecule order in the crystalline network, as this is essential for solving the tridimensional structure of the complex. "Obtaining a good crystal is a long and hard task and requires the collaboration of groups from different disciplines. With the help of synchrotrons like the ALBA, science can make a big step forward in comparison with the methods that were available 20 years ago," says Lourdes Campos.

In the next phase, researchers analysed the crystals of the complex of DNA with the drug using X-rays at the XALOC macromolecular diffraction beamline of the ALBA synchrotron. X-rays, when they pass through the crystal and diffract, project images of spots which, after mathematic analysis, can solve the tridimensional structure of a molecule. When MACROM researchers solved the 3D structure, they identified the details of CD27's structure, enabling the drug to recognise the regions of DNA covering the minor groove and preventing the development of the parasite. At the same time, these studies contribute to a rational design of new drugs, bearing in mind the molecular interactions caused by CD27.

Results of this research have been validated and deposited at the Protein Data Bank, a 3D database of proteins and nucleic acids, and published in the journal Acta Crystallographica D.

The drug is patent-free and can be produced by any pharmaceutical company interested in its development.

Malaria, responsible for more than one million deaths every year

Malaria is an infectious disease caused by a parasite of the Plasmodium genus that is transmitted by a mosquito bite. It deeply affects African countries, although it is also present in some areas of Latin America and Asia (with an estimated at-risk population of 3.4 billion, according to the World Health Organization). It is thought that malaria causes more than one million deaths every year and the parasite's resistance to existing drugs is an obstacle in the treatment of the disease.

The ALBA synchrotron

ALBA is the Spanish synchrotron light source. It is a complex of electron accelerators that produce synchrotron light, which allows the atomic structure of matter to be visualised and its properties to be studied.

ALBA has been in operation since May 2012 and has seven experimental beamlines.

This scientific infrastructure produces 5,000 hours of beamtime per year and is available for academics and the industrial sector and serves more than 1,000 researchers every year.


Story Source:

The above story is based on materials provided by Universitat Politècnica de Catalunya (UPC). Note: Materials may be edited for content and length.


Journal Reference:

  1. Francisco J. Acosta-Reyes, Christophe Dardonville, Harry P. de Koning, Manal Natto, Juan A. Subirana, J. Lourdes Campos. In and out of the minor groove: interaction of an AT-rich DNA with the drug CD27. Acta Crystallographica Section D Biological Crystallography, 2014; 70 (6): 1614 DOI: 10.1107/S139900471400697X

Cite This Page:

Universitat Politècnica de Catalunya (UPC). "New drug against malaria effective: Uses synchrotron light." ScienceDaily. ScienceDaily, 21 July 2014. <www.sciencedaily.com/releases/2014/07/140721100153.htm>.
Universitat Politècnica de Catalunya (UPC). (2014, July 21). New drug against malaria effective: Uses synchrotron light. ScienceDaily. Retrieved October 20, 2014 from www.sciencedaily.com/releases/2014/07/140721100153.htm
Universitat Politècnica de Catalunya (UPC). "New drug against malaria effective: Uses synchrotron light." ScienceDaily. www.sciencedaily.com/releases/2014/07/140721100153.htm (accessed October 20, 2014).

Share This



More Health & Medicine News

Monday, October 20, 2014

Featured Research

from universities, journals, and other organizations


Featured Videos

from AP, Reuters, AFP, and other news services

Microneedle Patch Promises Painless Pricks

Microneedle Patch Promises Painless Pricks

Reuters - Innovations Video Online (Oct. 18, 2014) — Researchers at The National University of Singapore have invented a new microneedle patch that could offer a faster and less painful delivery of drugs such as insulin and painkillers. Video provided by Reuters
Powered by NewsLook.com
Raw: Nurse Nina Pham Arrives in Maryland

Raw: Nurse Nina Pham Arrives in Maryland

AP (Oct. 17, 2014) — The first nurse to be diagnosed with Ebola at a Dallas hospital walked down the stairs of an executive jet into an ambulance at an airport in Frederick, Maryland, on Thursday. Pham will be treated at the National Institutes of Health. (Oct. 16) Video provided by AP
Powered by NewsLook.com
Raw: Cruise Ship Returns to US Over Ebola Fears

Raw: Cruise Ship Returns to US Over Ebola Fears

AP (Oct. 17, 2014) — A Caribbean cruise ship carrying a Dallas health care worker who is being monitored for signs of the Ebola virus is heading back to Texas, US, after being refused permission to dock in Cozumel, Mexico. (Oct. 17) Video provided by AP
Powered by NewsLook.com
Spanish Govt: Four Suspected Ebola Cases in Spain Test Negative

Spanish Govt: Four Suspected Ebola Cases in Spain Test Negative

AFP (Oct. 17, 2014) — All four suspected Ebola cases admitted to hospitals in Spain on Thursday have tested negative for the deadly virus in a first round of tests, the government said Friday. Duration: 00:55 Video provided by AFP
Powered by NewsLook.com

Search ScienceDaily

Number of stories in archives: 140,361

Find with keyword(s):
 
Enter a keyword or phrase to search ScienceDaily for related topics and research stories.

Save/Print:
Share:  

Breaking News:

Strange & Offbeat Stories

 

Health & Medicine

Mind & Brain

Living & Well

In Other News

... from NewsDaily.com

Science News

Health News

Environment News

Technology News



Save/Print:
Share:  

Free Subscriptions


Get the latest science news with ScienceDaily's free email newsletters, updated daily and weekly. Or view hourly updated newsfeeds in your RSS reader:

Get Social & Mobile


Keep up to date with the latest news from ScienceDaily via social networks and mobile apps:

Have Feedback?


Tell us what you think of ScienceDaily -- we welcome both positive and negative comments. Have any problems using the site? Questions?
Mobile iPhone Android Web
Follow Facebook Twitter Google+
Subscribe RSS Feeds Email Newsletters
Latest Headlines Health & Medicine Mind & Brain Space & Time Matter & Energy Computers & Math Plants & Animals Earth & Climate Fossils & Ruins